GREEN SYNTHESIZED SILVER NANOPARTICLES VIA PLANT EXTRACTS AS ANTI-MELANOMA AGENTS

  • Irina MACOVEI “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Anca MIRON “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Adina Catinca GRADINARU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ana Clara APROTOSOAIE “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

GREEN SYNTHESIZED SILVER NANOPARTICLES VIA PLANT EXTRACTS AS ANTI-MELANOMA AGENTS (Abstract): Melanoma is one of the most common and aggressive type of cancer. The actual treatment includes excisional surgery, electrochemotherapy and pharmacotherapy. The pharmaceutical treatment has major drawbacks such as severe side effects and development of drug resistance, fact that orientated the research towards the formulation of new drug delivery systems. Nanocarriers represent an innovative and alternative tool which significantly improves the bioavailability and site-specific targeting of pharmaceutical agents. Due to their biological activities, flexibility and reliability, silver nanoparticles (AgNPs) have gained high attention. The green synthesis of AgNPs, mediated by a plant extract, is an eco-friendly, cheap and effective method. Green synthesized AgNPs have been reported to develop cytotoxic effects against different tumor cell lines. With respect to melanoma, few studies have been conducted until now, but with promising results. The antitumor activity depends on the size and shape of AgNPs and relies on the synergistic effect between phytochemicals and nanocarriers. Overall, green synthesized AgNPs represent a promising strategy for melanoma treatment.

Author Biographies

Irina MACOVEI, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Pharmacognosy
Department of Drug Analysis

Anca MIRON, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Pharmacognosy

Adina Catinca GRADINARU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Pharmaceutical Botany

Ana Clara APROTOSOAIE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Pharmacognosy

References

1. Pautu V, Leonetti D, Lepeltier E, Clere N, Passirani C. Nanomedicine as a potent strategy in melanoma tumor microenvironment. Pharmacol Res 2017; 126: 31-53.
2. Craythorne E, Al-Niami F. Skin cancer. Medicine 2017; 45(7): 431-434.
3. Singh S, Zafar A, Khan S, Naseem I. Towards therapeutic advances in melanoma management: An overview. Life Sci J 2017; 174: 50-58.
4. Liu Y, Sheikh MS. Melanoma: Molecular Pathogenesis and Therapeutic Management. Mol Cell Pharmacol 2014; 6(3): 228-235.
5. Khodashenas B, Ghorbani H. Synthesis of silver nanoparticles with different shapes. Arab J Chem 2015; 8: 47-59.
6. Chen T, Wong Y-S, Zheng W, Bai Y, Huang L. Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solutions induce mitochondria-mediated apoptosis in A375 human melanoma cells. Colloids Surf B Biointerfaces 2008; 67: 26-31.
7. Jatariu A, Peptu C, Popa C, Indrei A. Micro- and nanoparticles-medical applications. Rev Med Chir 2009; 113(4): 1160-1168.
8. Maddinedi S, Mandal B, Maddili S. Biofabrication of size controllable silver nanoparticles – A green approach. J Photochem Photobiol B 2017; 167: 236-241.
9. Hoshyar R, Reza Khayati G, Poorgholami M, Kaykhaii M. A novel green one-step synthesis of gold nanoparticles using crocin and their anti-cancer activities. J Photochem Photobiol B 2016; 159: 237-242.
10. Pandian A, Karthikeyan C, Rajasimman M, Dinesh M. Synthesis of silver nanoparticle and its application. Ecotoxicol Environ Saf 2015; 121: 211-217.
11. Rao P, Nallappan D, Madhavi K, Rahman S, Wei L, Gan S. Phytochemicals and biogenic metallic nanoparticles as anticancer agents. Oxid Med Cell Longev 2016, doi.org/10.1155/2016/3685671.
12. Rajan R, Chandran K, Harper S, Yun S, Kalaichelvan T. Plant extract synthesized silver nanoparticles: An ongoing source of novel biocompatible materials. Ind Crops Prod 2015; 70: 356-373.
13. Wei L, Lu J, Xu H, Patel A, Chen Z, Chen G. Silver nanoparticles: synthesis, properties, and therapeutic applications. Drug Discov Today 2015; 20: 167-174.
14. Zhang X-F, Liu Z-G, Shen W, Gurunathan S. Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int J Mol Sci 2016; 17: 1534-1542.
15. Roy N, Gaur A, Jain A, Bhattacharya S, Rani V. Green synthesis of silver nanoparticles: An approach to overcome toxicity. Environ Toxicol Pharmacol 2013; 36: 807-812.
16. Beyene H, Werkneh A, Bezabh H, Ambaye T. Synthesis paradigm and applications of silver nanoparticles (AgNPs), a review. Sust Mat Technol 2017; 13: 18-23.
17. Priyadarshni KC, Mahalingam PU. Antimicrobial and anticancer activity of silver nanoparticles from edible mushroom: a review. Asian J Pharm Clin Res 2017; 10: 37-40.
18. Venkatesan J, Kim S-K, Shim MS. Antimicrobial, antioxidant, and anticancer activities of bio-synthesized silver nanoparticles using marine algae Ecklonia cava. Nanomaterials 2016; 6: 235-242.
19. Devi JS, Bhimba BV, Ratnam K. In vitro anticancer activity of silver nanoparticles synthesized using the extract of Gelidiella sp. Int J Pharm Sci 2012; 4: 710-715.
20. Virgen-Ortiz A, Apolinar-Iribe A. Green silver nanoparticles: novel therapeutic potential for cancer and microbial infections. J Nanomed Res 2017; 6: 00162.
21. Das S, Das J, Samadder A, Bhattacharya S, Das D, Khuda-Bukhsh A. Biosynthesised silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloids Surf B Biointerfaces 2013; 101: 325-336.
22. *** EMEA. Phytolacca Americana. Summary report, 1999. Available at: http://www.ema.europa.eu/ docs/ en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015650.pdf
23. Palit P, Mukherjee D, Mandal S. Reconstituted mother tinctures of Gelsemium sempervirens L. improve memory and cognitive in mice scopolamine-induced dementia model. J Ethnopharmacol 2015; 159: 274-284.
24. Saha K, Sikdar S, Mukherjee A, Bhadra K, Boujedani N, Khuda-Bukhsh A. Ethanolic extract of the Goldenseal, Hydrastis canadensis, has demonstrable chemopreventive effects on HeLa cells in vitro: Drug-DNA interaction with calf thymus DNA as target. Environ Toxicol Pharmacol 2013; 36: 202-214.
25. *** EMEA. Thuja occidentalis. Summary report, 1999. Available at: http://www.ema.europa.eu/ docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015550.pdf
26. Patra S, Mukherjee S, Barui A, Ganguly A, Sreedhar B, Patra C. Green synthesis, characterization of gold and silver nanoparticles and their potential application for cancer therapeutics Mater Sci Eng C 2015; 53: 298-309.
27. Jha D, Thiruveedula P, Pathak R, Kumar B, Gautam H, Agnihotri S et al. Multifunctional bio-synthesized silver nanoparticles exhibiting excellent antimicrobial potential against multi-drug resistant microbes along with remarkable ant cancerous properties. Mater Sci Eng 2017; 80: 659-669.
28. Vazhappilly CG, Vijayabhavanat VV, Dehigaspege IMA, Chelakkot AL, Kannan A, Devanga Ragupathi NK et al. Mechanisms of action of flavonoids in prevention of inflammation-associated skin cancer. Curr Med Chem 2016; 23: 1-20.
29. Ghosh S, Bishayee K, Khuda-Bukhsh AR. Oleanolic acid isolated from ethanolic extract of Phytolacca decandra induces apoptosis in A375 skin melanoma cells: drug-DNA interaction and signaling cascade. J Integr Med 2014; 12: 102-111.
Published
2018-10-04